17,971 reports of this reaction
1.2% of all ADALIMUMAB reports
#20 most reported adverse reaction
DEVICE ISSUE is the #20 most commonly reported adverse reaction for ADALIMUMAB, manufactured by AbbVie Inc.. There are 17,971 FDA adverse event reports linking ADALIMUMAB to DEVICE ISSUE. This represents approximately 1.2% of all 1,482,766 adverse event reports for this drug.
Patients taking ADALIMUMAB who experience device issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEVICE ISSUE is a less commonly reported adverse event for ADALIMUMAB, but still significant enough to appear in the safety profile.
In addition to device issue, the following adverse reactions have been reported for ADALIMUMAB:
The following drugs have also been linked to device issue in FDA adverse event reports:
DEVICE ISSUE has been reported as an adverse event in 17,971 FDA reports for ADALIMUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEVICE ISSUE accounts for approximately 1.2% of all adverse event reports for ADALIMUMAB, making it a notable side effect.
If you experience device issue while taking ADALIMUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.